Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Garrison

Showing results (231-240 of 316) with videos related to

Pageof 32
Sort By:
Plos Pathogens|January 5, 2011
The p53-target gene puma drives neutrophil-mediated protection against lethal bacterial sepsisSean P Garrison, Justin A Thornton, Hans Häcker, et al.
Journal of Personalized Medicine|November 10, 2016
Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to ValueYixi Chen, Gregory F Guzauskas, Chengming Gu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 29, 2021
Hemophilia Gene Therapy Value Assessment: Methodological Challenges and RecommendationsLouis P Garrison, Ed Pezalla, Adrian Towse, et al.
Journal of Medical Economics|November 26, 2014
Lifetime cost of everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the USAllison Perrin, Steven Sherman, Sumanta Pal, et al.
Ecology|October 1, 2024
Measuring the benefit of a defensive trait: Vigilance and survival probabilityWilliam H Ellsworth, Scott D Peacor, Richard B Chandler, et al.
Surgery|July 29, 2008
Bacterial-dependent up-regulation of intestinal bile acid binding protein and transport is FXR-mediated following ileo-cecal resectionChristopher M Dekaney, Douglas C von Allmen, Aaron P Garrison, et al.
The American Journal of Managed Care|December 1, 2015
Private sector risk-sharing agreements in the United States: trends, barriers, and prospectsLouis P Garrison, Josh J Carlson, Preeti S Bajaj, et al.
Scientific Reports|April 19, 2018
Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling studySimon de Montigny, Blythe J S Adamson, Benoît R Mâsse, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 13, 2016
Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leadersMelissa Thompson, Chris Henshall, Louis P Garrison, et al.
Obesity (Silver Spring, Md.)|February 9, 2012
BMI trajectories among the severely obese: results from an electronic medical record populationEdwin S Wong, Bruce C M Wang, Rafael Alfonso-Cristancho, et al.
Pageof 32

Showing results (231-240 of 316) with videos related to

Sort By:
Pageof 32
Plos Pathogens|January 5, 2011
The p53-target gene puma drives neutrophil-mediated protection against lethal bacterial sepsisSean P Garrison, Justin A Thornton, Hans Häcker, et al.
Journal of Personalized Medicine|November 10, 2016
Precision Health Economics and Outcomes Research to Support Precision Medicine: Big Data Meets Patient Heterogeneity on the Road to ValueYixi Chen, Gregory F Guzauskas, Chengming Gu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 29, 2021
Hemophilia Gene Therapy Value Assessment: Methodological Challenges and RecommendationsLouis P Garrison, Ed Pezalla, Adrian Towse, et al.
Journal of Medical Economics|November 26, 2014
Lifetime cost of everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the USAllison Perrin, Steven Sherman, Sumanta Pal, et al.
Ecology|October 1, 2024
Measuring the benefit of a defensive trait: Vigilance and survival probabilityWilliam H Ellsworth, Scott D Peacor, Richard B Chandler, et al.
Surgery|July 29, 2008
Bacterial-dependent up-regulation of intestinal bile acid binding protein and transport is FXR-mediated following ileo-cecal resectionChristopher M Dekaney, Douglas C von Allmen, Aaron P Garrison, et al.
The American Journal of Managed Care|December 1, 2015
Private sector risk-sharing agreements in the United States: trends, barriers, and prospectsLouis P Garrison, Josh J Carlson, Preeti S Bajaj, et al.
Scientific Reports|April 19, 2018
Projected effectiveness and added value of HIV vaccination campaigns in South Africa: A modeling studySimon de Montigny, Blythe J S Adamson, Benoît R Mâsse, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 13, 2016
Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leadersMelissa Thompson, Chris Henshall, Louis P Garrison, et al.
Obesity (Silver Spring, Md.)|February 9, 2012
BMI trajectories among the severely obese: results from an electronic medical record populationEdwin S Wong, Bruce C M Wang, Rafael Alfonso-Cristancho, et al.
Pageof 32